Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
Care Ratings expects Dr Lal PathLabs' revenue to grow by 11-12 per cent per annum in the near-to-medium term driven by ...
Dr Lal PathLabs - Read all the latest news headline updates on Dr Lal PathLabs. Get all the Dr Lal PathLabs breaking news updates, videos, photostories and more at Business Standard.
Earnings call Dr. Lal PathLabs delivered Q3 FY26 revenue growth of 10.6% YoY to INR 660 crore, with EBITDA before exceptionals up 16.3% and a margin of 27.2%. Patient volume growth was modest at 2.7% ...
Dr. Lal Path Labs hits a 52-week high driven by Dubai expansion, strong FY27 growth guidance, solid earnings performance, and ...
Small-cap mutual funds ramped up exposure to industrial products and pharmaceutical stocks in May 2026, with Vijaya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results